Literature DB >> 17216568

Polymorphism analysis of Epstein-Barr virus isolates of nasopharyngeal carcinoma biopsies from Tunisian patients.

Wajdi Ayadi1, Lamia Feki, Abdelmajid Khabir, Tahia Boudawara, Abdelmonem Ghorbel, Ilhem Charfeddine, Jamel Daoud, Mounir Frikha, Adnane Hammami, Héla Karray-Hakim.   

Abstract

Many studies suggest that the focal distribution of nasopharyngeal carcinoma (NPC) may be influenced not only by host genetics, diet and environments but also by interplay with Epstein-Barr virus (EBV) genetics. Specific EBV gene variants (the A and C types, the BamHI f configuration, a C terminal 30 bp deletion and a N terminal loss of an XhoI site in the BNLF1 gene) have been explored in high incidence areas in southern Asian NPC patients. In contrast, in Tunisia where NPC represents the most frequent type of Head and Neck cancer the distribution of these polymorphisms remains poorly investigated. In order to characterize the epidemiology of EBV variants in Tunisian NPC patients, we have investigated the A or B type of the EBV nuclear antigen (EBNA)2 gene, the C or D type of the BamHI W1/I1 region, the F/f variants of the BamHI F region and the presence or the absence of the XhoI site, 30 bp deletion and Taq1 site in the BNLF1 gene in 47 NPC biopsies, 12 being younger than 30 and 35 older than 30. Our results show a unique genetic profile of the tumor EBV strains regarding the A and D types, the prototype F and retention of the XhoI restriction site in the N terminal region of BNLF1 gene. With regard to the C terminal region of this gene, four genetic profiles were detected: (1) the occurrence of the 30 bp deletion in association with the Taq1 site in 39 cases (83%), (2) the presence of the Taq1 site by itself in 5 cases, (3) the occurrence of the 30 bp deletion by itself in 2 cases and (4) the occurrence of a new deletion of 81 bp covering the 30 bp deletion in association with the Taq1 site in one case. With the exception of the 81 bp deletion, which has not been previously described in the literature, the summarized results have shown the same genetic profile in Tunisian NPC tumor isolates as tumor isolates from other North African and Mediterranean countries. Hence, the observed EBV polymorphisms are not fully specific of to the Tunisian NPCs. Nevertheless, the notion of a divergence between North African and Asian tumor EBV isolates is reinforced by this study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216568     DOI: 10.1007/s11262-006-0051-2

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  38 in total

1.  Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients.

Authors:  Boutheina Hadhri-Guiga; Abdel-Majid Khabir; Raja Mokdad-Gargouri; Abdel-Monem Ghorbel; Mohamed Drira; Jamel Daoud; Mounir Frikha; Rachid Jlidi; Ali Gargouri
Journal:  Virus Res       Date:  2005-09-08       Impact factor: 3.303

Review 2.  [Nasopharyngeal carcinoma. Recent data].

Authors:  H Boussen; N Bouaouina; N Mokni-Baizig; A Gamoudi; L Chouchane; F Benna; A Ladgham
Journal:  Pathol Biol (Paris)       Date:  2005-02

3.  Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.

Authors:  M Peng; E Lundgren
Journal:  Oncogene       Date:  1992-09       Impact factor: 9.867

4.  EBV strain variation: geographical distribution and relation to disease state.

Authors:  M Abdel-Hamid; J J Chen; N Constantine; M Massoud; N Raab-Traub
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

5.  Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.

Authors:  M L Chen; C N Tsai; C L Liang; C H Shu; C R Huang; D Sulitzeanu; S T Liu; Y S Chang
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

6.  Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1.

Authors:  M Peng; E Lundgren
Journal:  Leukemia       Date:  1993-01       Impact factor: 11.528

7.  Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas.

Authors:  K Sandvej; S C Peh; B S Andresen; G Pallesen
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

8.  Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx.

Authors:  G Klein; B C Giovanella; T Lindahl; P J Fialkow; S Singh; J S Stehlin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

9.  A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection.

Authors:  J W Sixbey; P Shirley; M Sloas; N Raab-Traub; V Israele
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

10.  EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.

Authors:  Abdelmajid Khabir; Hela Karray; Sandrine Rodriguez; Mathieu Rosé; Jamel Daoud; Mounir Frikha; Tahia Boudawara; Jaap Middeldorp; Rachid Jlidi; Pierre Busson
Journal:  Virol J       Date:  2005-04-20       Impact factor: 4.099

View more
  7 in total

1.  The incidence of Epstein-Barr virus in nasopharyngeal carcinoma of Jordanian patients.

Authors:  Ismail Matalka; Mohammad Al Hamad; Maysa Al-Hussaini; Firas Q Alzoubi
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-16       Impact factor: 2.503

Review 2.  The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.

Authors:  Cindy M Chang; Kelly J Yu; Sam M Mbulaiteye; Allan Hildesheim; Kishor Bhatia
Journal:  Virus Res       Date:  2009-07-23       Impact factor: 3.303

3.  Characteristics of epstein barr virus variants associated with gastric carcinoma in Southern Tunisia.

Authors:  Dorra BenAyed-Guerfali; Wajdi Ayadi; Imen Miladi-Abdennadher; Abdelmajid Khabir; Tahia Sellami-Boudawara; Ali Gargouri; Raja Mokdad-Gargouri
Journal:  Virol J       Date:  2011-11-03       Impact factor: 4.099

4.  Association between Epstein-Barr Virus Gene Polymorphism and Breast Cancer Risk among Egyptian Females.

Authors:  Meravt Mashaly; Doaa Ghorab; Mohamed Hegazy; Mohamed Abdelkhalek; Khaled Gaballah; Rasha Elzehery
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

5.  The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies.

Authors:  Vivaldo G da Costa; Ariany C Marques-Silva; Marcos L Moreli
Journal:  Syst Rev       Date:  2015-04-13

6.  Associations of Epstein-Barr Virus DNA in PBMCs and the Subtypes with Breast Cancer Risk.

Authors:  Wei Zhang; Min-Yi Wang; Xue-Ling Wei; Ying Lin; Feng-Xi Su; Xiao-Ming Xie; Lu-Ying Tang; Ze-Fang Ren
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

Review 7.  A Review of Cancer Genetics and Genomics Studies in Africa.

Authors:  Solomon O Rotimi; Oluwakemi A Rotimi; Bodour Salhia
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.